CLIMB BIO INC (CLYM) Stock Analyst Ratings
NASDAQ:CLYM - Nasdaq - US28658R1068 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 86% to CLYM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.2. This target is 593.88% above the current price.
CLYM was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about CLYM.
In the previous month the buy percentage consensus was at a similar level.
CLYM was analyzed by 7 analysts. More opinions would make the average more meaningful.